Fidelity Select Biotechnology Portfolio (FBIOX)
25.95
+0.08
(+0.31%)
USD |
Dec 05 2025
FBIOX Asset Allocations & Exposures
Asset Allocation
As of September 30, 2025.
| Type | % Net |
|---|---|
| Cash | 0.95% |
| Stock | 98.19% |
| Bond | 0.56% |
| Convertible | 0.00% |
| Preferred | 0.50% |
| Other | -0.21% |
Market Capitalization
As of September 30, 2025
| Large | 37.81% |
| Mid | 10.80% |
| Small | 51.39% |
Region Exposure
| Americas | 82.46% |
|---|---|
|
North America
|
82.46% |
| Canada | 0.36% |
| United States | 82.10% |
|
Latin America
|
0.00% |
As of September 30, 2025. Region breakdown data is
calculated by using the long position holdings of the portfolio.
| Greater Europe | 15.07% |
|---|---|
| United Kingdom | 2.15% |
|
Europe Developed
|
12.92% |
| Belgium | 2.36% |
| Denmark | 3.72% |
| France | 1.35% |
| Germany | 0.27% |
| Ireland | 0.22% |
| Netherlands | 4.03% |
| Switzerland | 0.98% |
|
Europe Emerging
|
0.00% |
|
Africa And Middle East
|
0.00% |
| Greater Asia | 0.07% |
|---|---|
| Japan | 0.00% |
|
Australasia
|
0.00% |
|
Asia Developed
|
0.07% |
| Singapore | 0.07% |
|
Asia Emerging
|
0.00% |
| Unidentified Region | 2.40% |
|---|
Stock Sector Exposure
| Cyclical |
|
0.00% |
| Materials |
|
0.00% |
| Consumer Discretionary |
|
0.00% |
| Financials |
|
0.00% |
| Real Estate |
|
0.00% |
| Sensitive |
|
0.00% |
| Communication Services |
|
0.00% |
| Energy |
|
0.00% |
| Industrials |
|
0.00% |
| Information Technology |
|
0.00% |
| Defensive |
|
96.78% |
| Consumer Staples |
|
0.00% |
| Health Care |
|
96.78% |
| Utilities |
|
0.00% |
| Not Classified |
|
3.22% |
| Non Classified Equity |
|
1.69% |
| Not Classified - Non Equity |
|
1.53% |
As of September 30, 2025
Stock Style Exposure
| Large Cap Value | -- |
| Large Cap Core | -- |
| Large Cap Growth | -- |
| Mid Cap Value | -- |
| Mid Cap Core | -- |
| Mid Cap Growth | -- |
| Small Cap Value | -- |
| Small Cap Core | -- |
| Small Cap Growth | -- |